Answer
Methylthioninium chloride Proveblue is indicated for acute symptomatic treatment of methaemoglobinaemia induced by medicinal and chemical products in adults, children and adolescents aged 0–17 years.
Sources for this answer
- Methylthioninium chloride Proveblue 5 mg/ml solution for injectionProvepharm UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated
Sources checked